In support of this finding, Yu et al. also reported that through ChiP analysis, GLI1 directly regulates the expression of ABCG2 by binding to the same GLI-binding consensus site within the promoter to maintain putative gastric CSCs and to mediate cisplatin resistance in GC cell lines and xenografts [128]. Here, ABCG2 is linked to gastric cancer.